These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21788403)

  • 1. Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies BIRC6 as a potential therapeutic target.
    Van Houdt WJ; Emmink BL; Pham TV; Piersma SR; Verheem A; Vries RG; Fratantoni SA; Pronk A; Clevers H; Borel Rinkes IH; Jimenez CR; Kranenburg O
    Mol Cell Proteomics; 2011 Dec; 10(12):M111.011353. PubMed ID: 21788403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan.
    Emmink BL; Van Houdt WJ; Vries RG; Hoogwater FJ; Govaert KM; Verheem A; Nijkamp MW; Steller EJ; Jimenez CR; Clevers H; Borel Rinkes IH; Kranenburg O
    Gastroenterology; 2011 Jul; 141(1):269-78. PubMed ID: 21459094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The secretome of colon cancer stem cells contains drug-metabolizing enzymes.
    Emmink BL; Verheem A; Van Houdt WJ; Steller EJ; Govaert KM; Pham TV; Piersma SR; Borel Rinkes IH; Jimenez CR; Kranenburg O
    J Proteomics; 2013 Oct; 91():84-96. PubMed ID: 23835434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ER-Stress-Induced Differentiation Sensitizes Colon Cancer Stem Cells to Chemotherapy.
    Wielenga MCB; Colak S; Heijmans J; van Lidth de Jeude JF; Rodermond HM; Paton JC; Paton AW; Vermeulen L; Medema JP; van den Brink GR
    Cell Rep; 2015 Oct; 13(3):489-494. PubMed ID: 26456824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of Clonogenic KIT(+) Human Colon Tumor Cells Requires Secretion of Stem Cell Factor by Differentiated Tumor Cells.
    Fatrai S; van Schelven SJ; Ubink I; Govaert KM; Raats D; Koster J; Verheem A; Borel Rinkes IH; Kranenburg O
    Gastroenterology; 2015 Sep; 149(3):692-704. PubMed ID: 25962936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human colonic fibroblasts regulate stemness and chemotherapy resistance of colon cancer stem cells.
    Colak S; Medema JP
    Cell Cycle; 2016 Jun; 15(12):1531-7. PubMed ID: 25483065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verticillin A overcomes apoptosis resistance in human colon carcinoma through DNA methylation-dependent upregulation of BNIP3.
    Liu F; Liu Q; Yang D; Bollag WB; Robertson K; Wu P; Liu K
    Cancer Res; 2011 Nov; 71(21):6807-16. PubMed ID: 21911457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery.
    Fang DD; Kim YJ; Lee CN; Aggarwal S; McKinnon K; Mesmer D; Norton J; Birse CE; He T; Ruben SM; Moore PA
    Br J Cancer; 2010 Apr; 102(8):1265-75. PubMed ID: 20332776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SW480 colorectal cancer cells that naturally express Lgr5 are more sensitive to the most common chemotherapeutic agents than Lgr5-negative SW480 cells.
    Planutis AK; Holcombe RF; Planoutene MV; Planoutis KS
    Anticancer Drugs; 2015 Oct; 26(9):942-7. PubMed ID: 26196680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines.
    Liu Z; Qiu M; Tang QL; Liu M; Lang N; Bi F
    Chin J Cancer; 2010 Jul; 29(7):661-7. PubMed ID: 20591218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.
    El Khoury F; Corcos L; Durand S; Simon B; Le Jossic-Corcos C
    Int J Oncol; 2016 Dec; 49(6):2558-2568. PubMed ID: 27748801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis.
    Luk SU; Xue H; Cheng H; Lin D; Gout PW; Fazli L; Collins CC; Gleave ME; Wang Y
    Oncotarget; 2014 Aug; 5(16):6896-908. PubMed ID: 25071009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells.
    Ekblad L; Kjellström J; Johnsson A
    Anticancer Drugs; 2010 Jun; 21(5):523-31. PubMed ID: 20168208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of the antiapoptotic factor Livin contributes to cisplatin resistance in colon cancer cells.
    Ding ZY; Liu GH; Olsson B; Sun XF
    Tumour Biol; 2013 Apr; 34(2):683-93. PubMed ID: 23188704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteome of human colon cancer stem cells: a comparative analysis.
    Zou J; Yu XF; Bao ZJ; Dong J
    World J Gastroenterol; 2011 Mar; 17(10):1276-85. PubMed ID: 21455326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells.
    Oh PS; Patel VB; Sanders MA; Kanwar SS; Yu Y; Nautiyal J; Patel BB; Majumdar AP
    Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G347-55. PubMed ID: 21596996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized Medicine-Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids.
    Raghavan S; Mehta P; Ward MR; Bregenzer ME; Fleck EMA; Tan L; McLean K; Buckanovich RJ; Mehta G
    Clin Cancer Res; 2017 Nov; 23(22):6934-6945. PubMed ID: 28814433
    [No Abstract]   [Full Text] [Related]  

  • 20. Gene expression profile of metastatic colon cancer cells resistant to cisplatin-induced apoptosis.
    Huerta S; Harris DM; Jazirehi A; Bonavida B; Elashoff D; Livingston EH; Heber D
    Int J Oncol; 2003 Mar; 22(3):663-70. PubMed ID: 12579322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.